Active Ingredient : Semaglutide, a GLP-1 receptor agonist Mechanism of Action : According to FDA prescribing information, semaglutide works by: Increasing glucose-dependent insulin secretion Decreasing glucagon secretion Slowing gastric emptying Acting on centers in the brain that regulate appetite Clinical Trial Evidence - STEP Program : According to published data from the STEP 1 trial (New England Journal of Medicine, 2021): Study Design : 68-week randomized, double-blind, placebo-controlled trial 1,961 adults without diabetes Inclusion: BMI 30 or 27 with weight-related conditions Intervention: Once-weekly subcutaneous semaglutide 2.4 mg Lifestyle: 500-calorie deficit diet plus 150 minutes/week physical activity Primary Results : Semaglutide group: Average 14.9% body weight loss (approximately 33 lbs for 220 lb individual) Placebo group: Average 2.4% body weight loss (approximately 5 lbs for 220 lb individual) Difference: 12.4 percentage points (p 3 pounds/week associated with higher risk

If you inject in the evening or at night , the peak of any gastrointestinal discomfort may occur during sleep, potentially reducing its impact on daily life
Yes, but only under medical supervision
Semaglutide: A Guide to the Wonder Weight Loss Drug Size of your meal is more effective for weight loss than fasting, research shows Dr Tepper added: Individuals using the drugs to lose weight often do not realise the impact it will have on their face, and that, for many, the sudden weight loss is like winning a lottery Mega Millions
High-dose omega-3 fatty acids have been associated with an increased incidence of atrial fibrillation, and co-administration of garlic or omega-3 with anticoagulants may increase bleeding risk ( The convergence of nutrigenomics, metabolomics, and digital health technologies offers a vision of truly personalized supplementation
d , Quantification of the fraction genome altered from each patient split by PAM50 annotation